NO992229L - (4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor - Google Patents

(4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor

Info

Publication number
NO992229L
NO992229L NO992229A NO992229A NO992229L NO 992229 L NO992229 L NO 992229L NO 992229 A NO992229 A NO 992229A NO 992229 A NO992229 A NO 992229A NO 992229 L NO992229 L NO 992229L
Authority
NO
Norway
Prior art keywords
hiv protease
aminoinazol
diazepin
phenylmethyl
hexahydro
Prior art date
Application number
NO992229A
Other languages
English (en)
Norwegian (no)
Other versions
NO992229D0 (no
Inventor
James David Rodgers
Patrick Yuk-Sun Lam
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO992229D0 publication Critical patent/NO992229D0/no
Publication of NO992229L publication Critical patent/NO992229L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992229A 1996-11-08 1999-05-07 (4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor NO992229L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74710396A 1996-11-08 1996-11-08
US2974696P 1996-11-08 1996-11-08
PCT/US1997/020036 WO1998020009A1 (en) 1996-11-08 1997-11-04 (4r,5s,6s,7r)-hexahydro-1- [5-(3-aminoinazole)methyl] -3-butyl-5,6-dihydroxy-4,7-bis [phaenylmethyl] -2h-1,3-diazepin-2-one, its preparation and its use as hiv protease inhibitor

Publications (2)

Publication Number Publication Date
NO992229D0 NO992229D0 (no) 1999-05-07
NO992229L true NO992229L (no) 1999-06-07

Family

ID=26705295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992229A NO992229L (no) 1996-11-08 1999-05-07 (4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor

Country Status (19)

Country Link
EP (1) EP0937066A1 (ko)
JP (1) JP2001503429A (ko)
KR (1) KR20000053123A (ko)
CN (1) CN1235601A (ko)
AU (1) AU722489B2 (ko)
BR (1) BR9712755A (ko)
CA (1) CA2270963A1 (ko)
CZ (1) CZ157499A3 (ko)
EA (1) EA001154B1 (ko)
EE (1) EE9900187A (ko)
HU (1) HUP9904143A3 (ko)
IL (1) IL129726A0 (ko)
LV (1) LV12374B (ko)
NO (1) NO992229L (ko)
NZ (1) NZ335919A (ko)
PL (1) PL333412A1 (ko)
SI (1) SI9720071A (ko)
SK (1) SK59599A3 (ko)
WO (1) WO1998020009A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998043969A1 (en) * 1997-03-31 1998-10-08 Dupont Pharmaceuticals Company Indazoles of cyclic ureas useful as hiv protease inhibitors
AU4716299A (en) * 1998-06-24 2000-01-10 Emory University Use of 3'-azido-2',3'-dideoxyuridine in combination with further anti-hiv drugs for the manufacture of a medicament for the treatment of hiv
FR2810039B1 (fr) 2000-06-13 2007-05-25 Centre Nat Rech Scient Composes urees cycliques et leur procede de preparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) * 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
WO1993007128A1 (en) * 1991-10-11 1993-04-15 The Du Pont Merck Pharmaceutical Company Cyclic ureas and analogues useful as retroviral protease inhibitiors

Also Published As

Publication number Publication date
CN1235601A (zh) 1999-11-17
AU5103398A (en) 1998-05-29
SK59599A3 (en) 1999-12-10
BR9712755A (pt) 1999-10-19
EE9900187A (et) 1999-12-15
LV12374B (en) 2000-04-20
EA199900451A1 (ru) 1999-12-29
IL129726A0 (en) 2000-02-29
SI9720071A (sl) 1999-12-31
WO1998020009A1 (en) 1998-05-14
HUP9904143A2 (hu) 2000-06-28
PL333412A1 (en) 1999-12-06
KR20000053123A (ko) 2000-08-25
AU722489B2 (en) 2000-08-03
JP2001503429A (ja) 2001-03-13
CZ157499A3 (cs) 1999-11-17
NO992229D0 (no) 1999-05-07
EP0937066A1 (en) 1999-08-25
LV12374A (lv) 1999-11-20
NZ335919A (en) 2000-09-29
EA001154B1 (ru) 2000-10-30
CA2270963A1 (en) 1998-05-14
HUP9904143A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
NO20022095L (no) Heterocyklisk substituerte pyrazoloner
NO20051695L (no) Nye spirokondenserte kinazolinoner og deres anvendelse som fosfodiestereaseinbibitorer
NO20054195D0 (no) Isoksazolforbindelser som inhibitorer for varmesjokkproteiner
BR9908004A (pt) Composto, composição e método para prevençãoou supressão de uma infecção viral
WO2001029037A3 (en) Condensed naphthyridines as hiv reverse transcriptase inhibitors
DE60214179D1 (de) IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN
DE60211539D1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
WO2002018321A3 (en) Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
NO20035791L (no) Nye derivater av oksazolidinoner som antibakterielle midler
BR9811557A (pt) Derivados do 2-)4-aril ou heteroaril-piperazin-1-ilmetil)-1h-indol
ES2151600T3 (es) Derivados de n-(3-amino-2-hidroxibutil)sulfonamida utilizados como inhibidores de proteasa de vih.
NO20044549L (no) Bisykliske 6-alkaliden-penemer som beta-laktamaseinhibitorer
DK1165544T3 (da) Substituerede 1,4-dihydroindeno[1,2-c]pyrazoler som inhibitorer af tyrosinkinase
YU62504A (sh) Triciklična 2-pirimidonska jedinjenja korisna kao inhibitori hiv reverzne transkriptoze
NO992229L (no) (4R,5S,6S,7R)-heksahydro-1-[5-(3-aminoinazol)metyl]-3-butyl-5,6-dihydroksy-4,7-bis[fenylmetyl]-2H-1,3-diazepin-2-on, dens fremstilling og dens anvendelse som HIV-proteaseinhibitor
NO20044550L (no) Heterotrisyklyl 6-alkaliden-penemer som beta-laktamaseinhibitorer
MXPA04005809A (es) Inhibidores de proteinas quinasas.
WO2004002410A3 (en) 2,4-disubstituted-pyridine n-oxides useful as hiv reverse transcriptase inhibitors
NO983444D0 (no) Benzo(c)kinolizin derivater, deres fremstilling og anvendelse som 5<alfa>-reduktaseinhibitorer
WO2002018323A3 (en) Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
LT2003003A (en) Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel
NO992228L (no) 1-(3-aminoindazol-5-yl)-3-fenylmetyl-syklisk urea egnet som HIV protease inhibitor
WO2002018363A3 (en) 3-phenyl-propanoic acid derivatives as protein tyrosine phosphatase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application